Stoke Therapeutics, Inc. (STOK) Deferred Tax Assets, Valuation Allowance USD 2018 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Stoke Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2018 to 2023.
  • Stoke Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $133 M, a 36.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $133 M +$35.4 M +36.1% Dec 31, 2023 10-K 2024-03-25
Q4 2022 $97.9 M +$31.9 M +48.3% Dec 31, 2022 10-K 2024-03-25
Q4 2021 $66 M +$28.8 M +77.5% Dec 31, 2021 10-K 2023-03-06
Q4 2020 $37.2 M +$19.3 M +107% Dec 31, 2020 10-K 2022-03-10
Q4 2019 $17.9 M +$10.3 M +135% Dec 31, 2019 10-K 2021-03-09
Q4 2018 $7.63 M Dec 31, 2018 10-K 2020-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.